- Home
- APLT vs AMSF Comparison
APLT vs AMSF Comparison
Compare APLT & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APLT | AMSF |
|---|---|---|
| Founded | 2016 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Accident &Health Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.1M | 741.5M |
| IPO Year | 2019 | 2005 |
Fundamental Metrics
Financial Performance| Metric | APLT | AMSF |
|---|---|---|
| Price | $0.12 | $39.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $1.25 | ★ $58.33 |
| AVG Volume (30 Days) | ★ 9.3M | 172.8K |
| Earning Date | 11-13-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 6.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.60 |
| Revenue | $1,000,000.00 | ★ $309,746,000.00 |
| Revenue This Year | $124.18 | $4.26 |
| Revenue Next Year | $66.67 | $4.48 |
| P/E Ratio | ★ N/A | $15.17 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.10 | $36.34 |
| 52 Week High | $1.50 | $53.48 |
Technical Indicators
Market Signals| Indicator | APLT | AMSF |
|---|---|---|
| Relative Strength Index (RSI) | 25.95 | 48.94 |
| Support Level | $0.10 | $36.34 |
| Resistance Level | $0.13 | $39.56 |
| Average True Range (ATR) | 0.02 | 0.75 |
| MACD | 0.02 | 0.16 |
| Stochastic Oscillator | 13.10 | 67.31 |
Price Performance
Historical ComparisonAbout APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums.